Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) — BG-Speech-02  

Spinal Cord Injuries Clinical Trial

Official title: Understanding and Restoring Speech Production Using an Intracortical Brain-computer Interface

Status Recruiting

Clinical Trial Summary

The goal of this study is to improve our understanding of speech production, and to translate this into medical devices called intracortical brain-computer interfaces (iBCIs) that will enable people who have lost the ability to speak fluently to communicate via a computer just by trying to speak.

Clinical Trial Description

The goal is to develop a new way to help people who lose the ability to speak due to neurological conditions including ALS or stroke, using an implanted medical device called a "brain-computer interface". The implanted medical device measures the person's brain activity as they try to talk and outputs their intended speech. By bypassing the injured parts of the nervous system this way, we can observe how individual brain cells are involved in speaking and working together as a network, to produce speech, and we can learn to decipher this activity to output what the person is trying to say. ;

Related Conditions & MeSH terms

• Amyotrophic Lateral Sclerosis
• Brain Stem Infarctions
• Dysarthria
• Locked-in Syndrome
• Motor Neuron Disease
• Muscular Dystrophies
• Quadriplegia
• Spinal Cord Injuries
• Tetraplegia

• NCT number: NCT06094205
• Study type: Interventional
• Source: Massachusetts General Hospital
• Contact: Leigh R. Hochberg, M.D., Ph.D.
• Phone: 617-724-9247
• Email: lhochberg@mgh.harvard.edu
• Status: Recruiting
• Phase: N/A
• Start date: October 2024
• Completion date: August 31, 2027